Riad El-Dada - 10 Dec 2025 Form 4 Insider Report for Klotho Neurosciences, Inc. (KLTO)

Reporting relationship
Director
Issuer ticker
KLTO
Reported as of
10 Dec 2025
Net transaction value
+$8,200
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Dec 2025, 13:38:05 UTC
Prior SEC filing
08 Aug 2025
Next SEC filing
06 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Riad El-Dada

Key filing fact

Riad El-Dada filed Form 4 for Klotho Neurosciences, Inc. (KLTO) on 10 Dec 2025.

Key facts

  • This page summarizes Riad El-Dada's Form 4 filing for Klotho Neurosciences, Inc. (KLTO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Dec 2025, 13:38.

Change

  • Previous filing in this sequence was filed on 08 Aug 2025.
  • Current net transaction value: +$8,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001926018 Primary reporting owner

El-Dada Riad Hussein

Relationship
Director
Address
1300 SOUTH BOULEVARD SUITE D, CHARLOTTE
Signature
Riad El-Dada
Signature date
10 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KLTO transaction Derivative

Non-Qualified Stock Option

Award

Transaction value
$8,200
Shares
+20,000
Change %
+50%
Price
$0.4100
Shares after
60,000
Date
10 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$0.4100
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options are fully vested and can be exercised at any time.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .